LOBULAR BREAST CANCER ALLIANCE INC

EIN: 862260246 501(c)(3) Diseases & Disorders

WHITE HORSE BEACH, MA

Total Revenue
$1,379,467
Total Expenses
$894,593
Total Assets
$1,106,495
Net Assets
$1,083,135
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2021
Legal Domicile
DE
Principal Officer
LAURIE B HUTCHESON
Phone
6179211949
Tax Period
2024-07-01 to 2025-06-30

LOBULAR BREAST CANCER ALLIANCE INC, founded in 2021, is a community nonprofit in the Diseases & Disorders sector that reported $1.4M in total revenue in fiscal year 2024. Revenue surged 32% from the prior year, signaling strong growth momentum. The organization ran a surplus of $485K, a strong 35% operating margin.

Mission

AS THE ONLY ORGANIZATION IN THE US DEDICATED TO INVASIVE LOBULAR BREAST CANCER (ILC), LBCA'S MISSION IS TO MAKE ALL WHO ARE TOUCHED BY ILC AWARE OF ITS UNIQUE CHARACTERISTICS AND THE CRITICAL NEED FOR MORE ILC RESEARCH; TO BE THE GO-TO SOURCE FOR (CONT'D IN SCHEDULE O) INFORMATION ON ILC STUDIES, CLINICAL TRIALS AND EDUCATIONAL TOOLS; TO FOSTER PARTNERSHIPS AMONG PATIENTS, SCIENTISTS, CLINICIANS, AND BREAST CANCER ORGANIZATIONS TO INCREASE DIALOGUE ABOUT ILC AND RESEARCH ADVOCACY; AND TO FUND VITAL ILC RESEARCH.

Program Service Accomplishments

Program 1
Expenses: $673,762

DURING THE LAST FISCAL YEAR, LBCA:-LAUNCHED FIRST OCTOBER 15TH GLOBAL LOBULAR BREAST CANCER AWARENESS DAY IN COLLABORATION WITH ADVOCATES AND RESEARCHERS AROUND THE WORLD AND WORKED WITH A PR COMPANY...

Read more

DURING THE LAST FISCAL YEAR, LBCA:-LAUNCHED FIRST OCTOBER 15TH GLOBAL LOBULAR BREAST CANCER AWARENESS DAY IN COLLABORATION WITH ADVOCATES AND RESEARCHERS AROUND THE WORLD AND WORKED WITH A PR COMPANY TO RAISE AWARENESS OF ILC AND LBCA IN SEVERAL KEY METROPOLITAN AREAS AROUND THE US. WORKED WITH THREE MAJOR CANCER CENTERS (DANA FARBER, MEMORIAL SLOAN KETTERING AND MD ANDERSON) TO ENCOURAGE THEIR IMPLEMENTING OCT 15TH ILC AWARENESS RAISING EVENTS AND LAUNCHING THEIR OWN ILC PROGRAMS-SUPPORTED TWO AND LAUNCHED A THIRD LOCAL ADVOCACY TEAM (LAT) IN CASCADIA (OREGON AND WASHINGTON STATE REGION) TO INCREASE LBCA'S WORK WITH ADVOCATES CONDUCTING EDUCATION AND RESEARCH ADVOCACY IN THEIR COMMUNITIES (CONT'D IN SCHEDULE O) -CREATED ILC INFO GRAPHICS FOR CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) AND FOR NATIONAL CANCER INSTITUTE (NCI) BREAST CANCER PATIENT FACING PAGES -PRODUCED TEXT FOR REPORT ON ILC AND NCI SEER ILC INCIDENCE DATA THAT WAS PUBLISHED ON THE NCI CANCER STAT FACTS WEBPAGE AND WILL BE UPDATED ANNUALLY.-PRODUCED PATIENT RESOURCE DOCUMENT ON LOBULAR BREAST CANCER MYTHS AND FACTS-FUNDED ILC RESEARCH GRANTS WITH SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (SNMMI), ASCO / CONQUER CANCER FOUNDATION, AND AMERICAN ASSOCIATION FOR CANCER RESEARCH. FUNDED/ISSUED IN COLLABORATION WITH SUSAN G. KOMEN FIRST EVER METASTATIC ILC RESEARCH GRANT SOLICITATION IN MEMORY OF LBCA FOUNDING ADVOCATE JULIA K. LEVINE-HELPED AUSTRALIA LOBULAR BREAST CANCER PATIENTS FORM LBCA-AUS FOR PATIENT ADVOCACY AND HELPED BRAZILIAN CLINICIANS DEVELOP TRAINING CURRICULUM ON ILC FOR MDS.-SUPPORTED LAUNCH OF TWO VIRTUAL SUPPORT GROUPS FOR INDIVIDUALS WITH METASTATIC ILC-CO-SPONSORED AND PRESENTED POSTER ON LBCA'S OCTOBER 15TH MOVEMENT AT ILC SYMPOSIUM IN LEUVEN, BELGIUM IN SEPTEMBER 2024-PRODUCED AND PRESENTED POSTER ON ILC PATIENT EXPERIENCE WITH SURGICAL TREATMENT PLANNING IN DECEMBER AT SAN ANTONIO BREAST CANCER SYMPOSIUM 24-DEVELOPED AND SHARED ON WEBSITE AND SOCIAL MEDIA LAY SUMMARIES OF ALL ILC POSTERS PRESENTED AT SABCS 24, TO MAKE THE RESEARCH PRESENTED ACCESSIBLE TO LAY AUDIENCES-INITIATED, FUNDED AND AWARDED MERIT SCHOLARSHIPS (TO COVER CONFERENCE ATTENDANCE TRAVEL COSTS) FOR TOP FIVE BEST ILC RESEARCH POSTERS PRESENTED AT SABCS24 VIA ADMINISTRATIVE PARTNERSHIP WITH AACR. DEVELOPED AND SHARED ON WEBSITE/NEWSLETTER, LAY SUMMARIES OF 25 ILC RESEARCH POSTERS PRESENTED AT SABCS INCLUDING MERIT WINNERS.-MANAGED WEBSITE WITH (EVER-INCREASING HITS) THAT PROVIDES DETAILED INFORMATION FOR THE PUBLIC ABOUT INVASIVE LOBULAR BREAST CANCER (ILC), ILC RESEARCH, CLINICAL TRIALS AND PATIENT ADVOCACY OPPORTUNITIES. -HOSTED 4 WEBINARS FOR ILC PATIENT ADVOCATES ON RESEARCH AND OTHER TOPICS, AND PROVIDED 17 TRAVEL SCHOLARSHIPS TO PATIENT ADVOCATES TO ATTEND TRAININGS AND CONFERENCES-RELEASED 2 ILC CURRICULUMS FOR CLINICIANS AVAILABLE FOR VIEWING AS WEBINARS FOR CMES ON MEMORIAL SLOAN KETTERING (MSK) CANCER CENTER EDUCATIONAL PORTAL-SPONSORED SCIENTIFIC ADVISORY BOARD MEETINGS TO INVOLVE ILC RESEARCHERS IN ADVOCACY AND IN THE DEVELOPMENT OF THE INFORMATION LBCA DISSEMINATES-SPONSORED PATIENT ADVOCATE ADVISORY BOARD MEETINGS TO INVOLVE ILC PATIENT ADVOCATES IN ILC AWARENESS RAISING ACTIVITIES AND STRATEGIC PLANNING-PUBLISHED MONTHLY NEWSLETTER REACHING OVER 7,200 SUBSCRIBERS-ADDED 60+ NEW ILC STUDIES TO THE JULIA K. LEVINE ILC PUBLICATIONS LIBRARY ON THE LBCA WEBSITE

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $1,351,670
Program Service Revenue $0
Investment Income $27,774
Other Revenue $23
TOTAL REVENUE $1,379,467

Expense Breakdown

Grants Paid $362,583
Salaries & Benefits $349,065
Fundraising Expenses $121,994
Program Expenses $673,762
Other Expenses $182,945
TOTAL EXPENSES $894,593

Year-over-Year Comparison

2024 2023 Change
Revenue $1,379,467 $1,043,541 +0.3%
Expenses $894,593 $743,557 +0.2%
Net Income $484,874 $299,984 +0.6%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
8
Independent Members
7
Employees
7
Volunteers
81

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
7
$168,473
Total Directors
9
$117,277
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
LAURIE B HUTCHESON MS PRESIDENT, ED, & DIRECTOR 50.00
Officer Director
$117,277 $0 $117,277
BRENDA CUNNINGTON DIRECTOR 1.00
Director
$0 $0 $0
TANYA MARTIN-DICK DIRECTOR (LEFT 7/2024) 1.00
Director
$0 $0 $0
JUDY MCDEVITT DIRECTOR 1.00
Director
$0 $0 $0
KATHRYN KRANTZ DIRECTOR 1.00
Director
$0 $0 $0
JOHN DOSKI MD DIRECTOR (JOINED 2/2025) 1.00
Director
$0 $0 $0
TRACY CUSHING MD MPH DIRECTOR & BOARD CHAIR (LEFT 6/2024) 1.00
Officer Director
$0 $0 $0
ROBERT W OAKES JR CPA MBA TREASURER & DIRECTOR 3.00
Officer Director
$0 $0 $0
ROBERT MCDEVITT DIR (07/2024)&BOARD CHAIR (10/2024) 1.00
Officer Director
$0 $0 $0
MASON MITCHELL-DANIELS MSW MPH VICE PRESIDENT & COO 20.00
Officer
$51,196 $0 $51,196
JOSEPH C HUTCHESON II JD MBA SEC. & GEN COUNSEL (LEFT 11/2024) 10.00
Officer
$0 $0 $0
MEGAN MEDEIROS SEC. & GEN COUNSEL (JOINED 12/2024) 10.00
Officer
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 $1,379,467 $894,593 $1,106,495 $484,874
2024 $1,043,541 $743,557 $640,464 $299,984
2023 $599,581 $526,217 $380,388 $73,364
2022 $416,482 $191,569 $236,186 $224,913
Explore More Nonprofits
Top 100 Nonprofits in Massachusetts Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare LOBULAR BREAST CANCER ALLIANCE INC with other nonprofits in Massachusetts and across the country.